AAMU
RETA

Amundi Asset Management US’s Reata Pharmaceuticals, Inc. Class A Common Stock RETA Stock Holding History

Amundi Asset Management US’s Portfolio RETA Stock Details RETA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-117,758
Closed -$14.6M – 1586
2020
Q4 		$14.6M Sell
117,758
-7,076
-6% -$930K 0.01% 720
2020
Q3 		$12.2M Sell
124,834
-3,584
-3% -$448K 0.01% 683
2020
Q2 		$20M Sell
128,418
-10,379
-7% -$1.58M 0.02% 509
2020
Q1 		$20M Sell
138,797
-3,593
-3% -$694K 0.03% 403
2019
Q4 		$29.1M Sell
142,390
-43,801
-24% -$7.99M 0.03% 449
2019
Q3 		$14.9M Buy
186,191
+2,272
+1% +$193K 0.02% 600
2019
Q2 		$17.4M Buy
183,919
+49,814
+37% +$4.3M 0.01% 629
2019
Q1 		$11.5M Buy
+134,105
New +$11.1M 0.02% 677

Other funds holding RETA

Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
CI
CPMG Inc Dallas, Texas $37.1M AUM 74.35% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $653B AUM 32.41% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
DFO
Duquesne Family Office New York $2.94B AUM 61.92% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return